Back to all studies
CompletedNCT03019497

Cognitive-behavioral Therapy for Treatment of PTSD and Related Problems

This study is completed. It focuses on PTSD and currently lists study information in Canada.

PTSDBehavioralFrom 18 Years to 70 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT03019497. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether Specific Modules may be useful for adults experiencing ptsd.

What would participation involve?

Participants may take part in Specific Modules, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in Canada.

Who is it mainly for?

This study appears to be mainly for adults with ptsd.

What should you check before joining?

Ask about how many sessions are required and who delivers them, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Completed
Estimated enrollment
92
Sponsor
Université de Montréal
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Canada
Age range
From 18 Years to 70 Years
Official registry ID
NCT03019497
Official title
Towards Optimization of Traumatic Cognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related Problems
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT03019497. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help test a support approach in real life.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: The purpose of this study is to evaluate the efficacy of a form of cognitive behavioral therapy (CBT) in a population of individuals with PTSD and common related problems (depression, anxiety or sleep disorders, pain, psychosocial stressors, low social support, substance use. The study team can confirm the exact objective and what it means for you.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving Specific Modules, Cognitive behavioral therapy. Phase is mainly useful to check for medication studies and some device studies.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Will I need to change, stop, or stabilize my current treatment?

The public registry appears to mention rules about current treatment, stability, stopping treatment, or dose changes. Do not change your treatment for a study without medical guidance. Ask the study team and your clinician what is required, what is not allowed, and how safety is monitored.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Université de Montréal, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join. The registry lists an estimated enrollment of 92 participants.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me